In mice with epilepsy, treatment with SFN resulted in a notable elevation in the levels of Nrf2, NQO1, and HO‐1 in brain tissue (Sandouka and Shekh‐Ahmad 2021). The gene discussed is NQO1; the disease is epilepsy.